{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:42Z","timestamp":1758588162088,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z181100001718220"],"award-info":[{"award-number":["Z181100001718220"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.transproceed.2020.10.045","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T00:46:08Z","timestamp":1608857168000},"page":"1308-1312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-transplant Lymphoproliferative Disorder in Recipient\u2019s Reconstructed Middle Hepatic Vein After Pediatric Living Donor Liver Transplant: A Case Report"],"prefix":"10.1016","volume":"53","author":[{"given":"Hongyu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2020.10.045_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00007890-200210270-00008","article-title":"Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients","volume":"74","author":"Duvoux","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.10.045_bib2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2020.10.045_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/lt.23659","article-title":"Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience","volume":"19","author":"Narkewicz","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2020.10.045_bib4","first-page":"31","article-title":"Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease","volume":"73","author":"Aguayo-Hiraldo","year":"2016","journal-title":"Bol Med Hosp Infant Mex"},{"key":"10.1016\/j.transproceed.2020.10.045_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2015.08.007","article-title":"Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment","volume":"369","author":"Petrara","year":"2015","journal-title":"Cancer Lett"},{"issue":"5 Pt 1","key":"10.1016\/j.transproceed.2020.10.045_bib6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-6143.2006.01294.x","article-title":"Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival","volume":"6","author":"Kremers","year":"2006","journal-title":"Am J Transplant"},{"issue":"Suppl. 2","key":"10.1016\/j.transproceed.2020.10.045_bib7","first-page":"79","article-title":"Lymphoproliferative disease after pediatric liver transplant","volume":"15","author":"Ozcay","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2020.10.045_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00007890-200003150-00027","article-title":"Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant","volume":"69","author":"Dotti","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.10.045_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.13213","article-title":"Managing the challenge of PTLD in liver and bowel transplant recipients","volume":"169","author":"Lauro","year":"2015","journal-title":"Br J Haematol"},{"issue":"Suppl. 7","key":"10.1016\/j.transproceed.2020.10.045_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1469-0691.12534","article-title":"Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients","volume":"20","author":"San-Juan","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.transproceed.2020.10.045_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","article-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?","volume":"79","author":"Ghobrial","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.10.045_bib12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.transproceed.2020.10.045_bib13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3748\/wjg.v23.i7.1224","article-title":"Post-transplant lymphoproliferative disorder after liver transplantation: incidence, long-term survival and impact of serum tacrolimus level","volume":"23","author":"Eshraghian","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2020.10.045_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.transproceed.2020.10.045_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00043426-200101000-00005","article-title":"Posttransplant lymphoproliferative disease in children: correlation of histology to clinical behavior","volume":"23","author":"Hayashi","year":"2001","journal-title":"J\u00a0Pediatr Hematol Oncol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134520328888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134520328888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:39:20Z","timestamp":1758577160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134520328888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0041134520328888"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.10.045","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-transplant Lymphoproliferative Disorder in Recipient\u2019s Reconstructed Middle Hepatic Vein After Pediatric Living Donor Liver Transplant: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.10.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}